Skip to main content

Table 3 Tumor types in 747 women or men patients

From: Effects of APOE gene ε4 allele on serum lipid profiles and risk of cardiovascular disease and tumorigenesis in southern Chinese population

Type Number (%)   
Men (N = 503) Women (N = 244) Total (N = 747)
Lung cancer 119 (23.7%) 32 (13.1%) 151 (20.2%)
Colorectal cancer 86 (17.1%) 41 (16.8%) 127 (17%)
Esophagus cancer 52 (10.3%) 21 (8.6%) 73 (9.8%)
Liver cancer 55 (10.9%) 10 (4.1%) 65 (8.7%)
Nasopharynx cancer 31 (6.2%) 8 (3.3%) 39 (5.2%)
Pituitary tumor 15 (3%) 20 (8.2%) 35 (4.7%)
Stomach cancer 21 (4.2%) 11 (4.5%) 32 (4.3%)
Breast cancer / 28 (11.5%) 28 (3.7%)
Neurologic tumor 16 (3.2%) 11 (4.5%) 27 (3.6%)
Prostatic cancer 24 (4.8%) / 24 (3.2%)
Hematological malignancies 14 (2.8%) 9 (3.7%) 23 (3.1%)
Cervical cancer / 20 (8.2%) 20 (2.7%)
Bladder cancer 16 (3.2%) 1 (0.4%) 17 (2.3%)
Thyroid cancer 3 (0.6%) 8 (3.3%) 11 (1.5%)
Renal cancer 6 (1.2%) 1 (0.4%) 7 (0.9%)
Laryngocarcinoma 6 (1.2%) / 6 (0.8%)
Ovarian cancer / 6 (2.5%) 6 (0.8%)
Gastrointestinal stromal tumor 3 (0.6%) 2 (0.8%) 5 (0.7%)
Pancreatic cancer 3 (0.6%) 2 (0.8%) 5 (0.7%)
Thymic carcinoma 2 (0.4%) 2 (0.8%) 4 (0.5%)
Adrenal tumor 3 (0.6%) / 3 (0.4%)
Endometrial cancer / 3 (1.2%) 3 (0.4%)
More than two cancers 22 (10.9%) 4 (1.6%) 26 (3.5%)
Others 6 (1.2%) 4 (1.6%) 10 (1.3%)